News & Events

Peapod Bio in the news and on the road.

Event

Peapod Bio sponsoring SLAS Chicago Meet-Up

Join the Society of Laboratory Automation and Screening (SLAS) and the Chicago life sciences community at this regional meet-up, featuring a panel discussion “Assay to Asset: How Automation, AI, and New Business Models are Reshaping Early Drug Discovery.” Learn from our expert panel, including Shana Kelley, Professor of Chemistry and Biomedical Engineering, Northwestern University and…

All News & Events

SLAS Europe 2026

Meet with Peapod Bio at the SLAS Europe 2026 Conference and Exhibition! May 19-21, 2026 | Vienna, Austria Poster Presentation:Poly A Polymerase Associated Domain enzyme inhibitors using an innovative mass spectrometry platformWednesday, May 20 | 1:30 PM – 2:30 PM Local Time | Poster #: 1042-APoster Session A in Exhibition Hall BTo schedule a meeting […]
News

Peapod Bio appoints Michael Scholle, MS, MBA to Board of Directors

Appointment brings over fifteen years as a CRO executive Peapod Bio, Inc, an industry leading contract research organization for small molecule assay development and high-throughput screening solutions, announced the appointment of Michael Scholle, MS, MBA, to its board of directors, effective immediately. Scholle brings over twenty-five years of experience in assay development and high-throughput screening […]
News

Peapod Bio Announces In-House 200,000-Compound Library Through Partnership with Enamine

Peapod Bio is excited to announce a new partnership with Enamine, Ltd, a global leader in small-molecule libraries, significantly expanding the discovery power available to our clients. Through this collaboration, Peapod Bio now offers an in-house collection of 200,000 diverse, pharmacophore-like compounds, available as singletons or pooled formats to be screened using a wide array of biochemical and affinity […]
Event

SLAS 2026

Visit Peapod Bio at the 2026 SLAS International Conference & Exhibition! February 7-11, 2026 | Boston, MA Booth #1129 Mark your calendars to join our Solution Spotlight presentation, poster presentation, and panels. Solutions Spotlight: Now you see it! High-throughput screening using MALDI MS and polymeric enrichment arrays (PEAs) to visualize the invisible Monday, February 9 […]
Event

Peapod Bio CEO Zachary Gurard-Levin to present a Webinar November 18, 2025 hosted by Bruker.

Title: The evolution of combining surface chemistry and MALDI mass spectrometry: A powerful foundation for high-throughput screening When: November 18, 2025 at 11:00 am EDT | 8:00 am PDT | 5:00 pm CEST followed by live Q&A. In this webinar hosted by Bruker, Gurard-Levin will discuss the development of different surface chemistries and their applications […]
News

Peapod Bio, Inc. launches with innovative assays and drug discovery services

Peapod Bio, Inc., a new contract research organization (CRO), launches to offer small molecule assay development and high-throughput screening (HTS) services using label-free and optical technologies. Our innovative mass spectrometry platform, powered by polymeric enrichment arrays (PEAs) and state-of-the-art MALDI instrumentation, accelerates the characterization of biochemical activities and binding interactions for virtually any target. With […]
Event

Meet Peapod Bio CEO in Boston September 23-24 at Discovery on Target 2025!

Peapod Bio Chief Executive Officer and Founder Zachary Gurard-Levin, PhD is attending the Discovery on Target Conference in Boston September 23-24. Click below to schedule a meeting to learn more about Peapod Bio’s innovative assay solutions to accelerate your drug discovery research.
News

Tango Biosciences Appoints Zachary Gurard-Levin, PhD to Board of Directors

Tango Biosciences, Inc., the premier contract research organization for custom affinity reagents by phage display, announced the appointment of Zachary Gurard-Levin, PhD, to its board of directors effective immediately. Gurard-Levin brings over two decades of experience in assay development and driving successful research programs for biotech…